Corrigendum to “role of P2X3 Receptor in Myocardial Ischemia Injury and Nociceptive Sensory Transmission” [auton. Neurosci.: Basic Clin. Volume 139, (issues 1–2), (30 May 2008), Pages 30–37]

Yunxia Wang,Guiling Li,Shangdong Liang,Aixia Zhang,Changshui Xu,Yun Gao,Chunping Zhang,Fang Wan

DOI: https://doi.org/10.1016/j.autneu.2019.102587

2019-01-01

Abstract:Due to the authors' carelessness, we mistakenly used same image in situ hybridization between the Fig. 6a [control group (A)] and Fig. 6c [myocardial ischemic rat treated with A-317491 (C)] for the expression of P2X3 mRNA in the myocardium cells of rat. We repeated the experiment again, and the data accorded with the trend of the original results. Original Fig. 6 Corrected photo for control group (A) in Fig. 6a is replaced. Corrected Fig. 6 Original Fig.7 P2X3 protein staining missing β-actin. Original Fig.7 Corrected P2X3 protein staining containing β-actin is replaced. Corrected Fig. 7 We would like to extend our apologies to the readers and to the editorial board for the Autonomic Neuroscience: Basic and Clinical. Role of P2X3 receptor in myocardial ischemia injury and nociceptive sensory transmissionAutonomic Neuroscience: Basic and ClinicalVol. 139Issues 1-2PreviewExtracellular ATP acts on purinergic receptors as a potent agonist for a variety of different cell types, including cardiomyocytes and nodose ganglia. P2X3 receptor is the most abundant P2X-receptor subtype in heart and nodose ganglia. This study wants to observe the role of P2X3 receptor in myocardial ischemic injury and nociceptive transmission via nodose ganglia. The serum lactate dehydrogenase (LDH), creatine kinase (CK) and CK isoform MB (CK-MB) activities were measured by automatic biochemistry analyzer. Full-Text PDF